<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5131993</article-id><article-id pub-id-type="pmid">27907198</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0167532</article-id><article-id pub-id-type="publisher-id">PONE-D-16-31023</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Molecular Biology Assays and Analysis Techniques</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Molecular Biology Assays and Analysis Techniques</subject><subj-group><subject>Phylogenetic Analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Sequencing techniques</subject><subj-group><subject>Sequence analysis</subject><subj-group><subject>DNA sequence analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Sequencing techniques</subject><subj-group><subject>Sequence analysis</subject><subj-group><subject>DNA sequence analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Asia</subject><subj-group><subject>Taiwan</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Enterovirus Infection</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Sequencing Techniques</subject><subj-group><subject>Sequence Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Sequencing Techniques</subject><subj-group><subject>Sequence Analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Computer and Information Sciences</subject><subj-group><subject>Data Management</subject><subj-group><subject>Taxonomy</subject><subj-group><subject>Evolutionary Systematics</subject><subj-group><subject>Phylogenetics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Population Biology</subject><subj-group><subject>Population Dynamics</subject><subj-group><subject>Geographic Distribution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Enteroviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Enteroviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Enteroviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Enteroviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>A Molecular Approach Applied to Enteroviruses Surveillance in Northern Taiwan, 2008-2012</article-title><alt-title alt-title-type="running-head">A Molecular Approach Applied to Enteroviruses Surveillance in Northern Taiwan, 2008-2012</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chung</surname><given-names>Wan-Yu</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chiang</surname><given-names>Pai-Shan</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Luo</surname><given-names>Shu-Ting</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Tzou-Yien</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tsao</surname><given-names>Kuo-Chien</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Min-Shi</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes (NHRI), Zhunan Town, Miaoli County, Taiwan</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Pediatrics, Chang Gung Memorial Hospital, Guishan Dist, Taoyuan City, Taiwan</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Guishan Dist, Taoyuan City, Taiwan</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Guishan Dist, Taoyuan City, Taiwan</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Department of Clinical Pathology, Chang Gung Memorial Hospital, Guishan Dist, Taoyuan City, Taiwan</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Jin</surname><given-names>Dong-Yan</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Hong Kong, HONG KONG</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors declare no competing financial interests.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> MSL TYL.</p></list-item><list-item><p><bold>Data curation:</bold> STL.</p></list-item><list-item><p><bold>Formal analysis:</bold> WYC STL MSL.</p></list-item><list-item><p><bold>Funding acquisition:</bold> MSL TYL.</p></list-item><list-item><p><bold>Investigation:</bold> PSC.</p></list-item><list-item><p><bold>Methodology:</bold> WYC PSC KCT.</p></list-item><list-item><p><bold>Project administration:</bold> MSL TYL KCT.</p></list-item><list-item><p><bold>Resources:</bold> KCT TYL MSL.</p></list-item><list-item><p><bold>Software:</bold> STL.</p></list-item><list-item><p><bold>Supervision:</bold> MSL TYL KCT.</p></list-item><list-item><p><bold>Validation:</bold> STL MSL.</p></list-item><list-item><p><bold>Visualization:</bold> WYC STL PSC.</p></list-item><list-item><p><bold>Writing &#x02013; original draft:</bold> MSL PSC.</p></list-item><list-item><p><bold>Writing &#x02013; review &#x00026; editing:</bold> MSL.</p></list-item></list></p></fn><corresp id="cor001">* E-mail: <email>minshi.lee@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>1</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>12</issue><elocation-id>e0167532</elocation-id><history><date date-type="received"><day>3</day><month>8</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Chung et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Chung et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0167532.pdf"/><abstract><p>Traditional methods for detection and serotyping of enterovirus infections are virus isolation and immunofluorescence assay (VI-IFA), which are labor-intensive and time-consuming. Recently, VP1 gene has been targeted to develop a CODEHOP-based RT-PCR (VP1-CODEHOP) for the same purpose. In this study, we conducted a 5-year enterovirus surveillance comparing the VI-IFA and VP1-CODEHOP tests. Throat swabs were collected from 431 pediatric patients and 208(48%) and 250(58%) were tested positive by the VI-IFA and VP1-CODEHOP tests, respectively. Among the 47 cases who had inconsistent results between the VI-IFA and VP1-CODEHOP tests and provided paired sera for serological verifications, correct diagnosis for the VI-IFA and VP1-CODEHOP were 5(11%) and 40(85%) cases, respectively. Therefore, the VP1-CODEHOP is more reliable for detection of human enteroviruses than the VI-IFA. Based on serological verifications for the eight cases who had inconsistent serotypes between the two tests and provided paired sera, five and two showed consistent serotypes with the VP1-CODEHOP and VI-IFA tests, respectively. CVA16, CVA6 and EV71 were the most prevalent serotypes in northern Taiwan, 2008~2012. Moreover, variant CVA2, CVA6 and EV71 viruses were further identified based on phylogenetic analysis of partial VP1 sequences. In conclusion, the VP1-CODEHOP test could be used as the primary method for enterovirus surveillance to support decision-making for outbreak control.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>National Health Reaserch Institutes</institution></funding-source><principal-award-recipient><name><surname>Lee</surname><given-names>Min-Shi</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by the National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="6"/><table-count count="5"/><page-count count="16"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Human enteroviruses are single-stranded, positive-sense RNA viruses in the Picornaviridae family and have been classified into four species including over 100 serotypes. With the exceptions of polioviruses, enterovirus 71 (EV71) and some Coxsackievirus group B, neurological complications due to other enteroviruses are relatively infrequent [<xref rid="pone.0167532.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0167532.ref002" ref-type="bibr">2</xref>]. A nationwide EV71 epidemic occurred in Taiwan in 1998. Since then, three national enterovirus surveillance platforms have been gradually established by Taiwan Centers for Disease Control (CDC), including (1) a sentinel physician network to collect weekly number of HFMD and herpangina, which was recently replaced by the Real-time Outbreak and Disease Surveillance through the National Health Insurance Database [<xref rid="pone.0167532.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0167532.ref004" ref-type="bibr">4</xref>]; (2) a contracted laboratory network for virus identification by collecting throat swabs from enterovirus-like patients (herpangina and HFMD); and (3) mandatory notification of enterovirus-like severe cases and collection of throat swab, serum, and contact information through an epidemiological investigation.</p><p>The traditional methods for detection and serotyping of enterovirus infections are virus isolation and immunofluorescence assay (VI-IFA), which are labor-intensive and time-consuming but are widely used in enterovirus surveillance system in Taiwan and other countries. In addition, the VI-IFA test requires 7&#x02013;14 days to complete detection and serotyping and cannot provide rapid laboratory diagnosis to support decision-making for controlling EV71-related outbreaks. Therefore, many local governments in Taiwan have set up enterovirus-related class-suspension policies based on clinical diagnosis to control enterovirus epidemics in day care centers, kindergartens, and elementary schools since 2005. For example, Taipei City government has established the following three scenarios for class suspension: 1) More than one student are clinically diagnosed with HFMD or herpangina by physicians within one week, the corresponding class will be suspended immediately; 2) After the first EV71-related severe case is detected in Taipei City, classes with one EV71 confirmed case will be suspended immediately; and 3) when an enterovirus-related cluster occurs in a school, classes with any HFMD and herpangina case in the same school will be suspended. The class-suspension policy relying on clinical diagnosis but not laboratory diagnosis could lead to unnecessary class suspension and cause indirect social burden. Therefore, it is desirable to develop rapid laboratory diagnosis for class suspension and case management in the enterovirus surveillance system. Previous studies have documented that molecular diagnosis based on polymerase chain reaction (PCR) is more time-saving and sensitive than the VI-IFA for detection of EV71 infections in inpatients [<xref rid="pone.0167532.ref005" ref-type="bibr">5</xref>&#x02013;<xref rid="pone.0167532.ref007" ref-type="bibr">7</xref>] and outpatients [<xref rid="pone.0167532.ref008" ref-type="bibr">8</xref>]. Besides, a novel molecular method using the consensus degenerate hybrid oligonucleotide primer (CODEHOP) has been developed to detect and identify distant-related pathogens with limited primers instead of a large number of primers. Moreover, CODEHOP can amplify genes with high variations instead of conserved regions to provide a better ability for identifying serotypes than traditional degenerate primers [<xref rid="pone.0167532.ref009" ref-type="bibr">9</xref>]. Serotyping based on phylogenetic analysis of the enterovirus VP1 capsid genes correlates with the serotyping using monoclonal antibody-based IFA [<xref rid="pone.0167532.ref010" ref-type="bibr">10</xref>]. Therefore, the enterovirus VP1 gene has been targeted to develop a CODEHOP-based reverse-transcriptase (RT) PCR (VP1-CODEHOP) for serotyping of enterovirus clinical isolates. Recently, accuracy of the VP1-CODEHOP test was further confirmed to be higher than that of the 5'-UTR RT-PCR and VI-IFA for detection and serotyping of enterovirus infections using throat swabs collected from pediatric outpatients [<xref rid="pone.0167532.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0167532.ref011" ref-type="bibr">11</xref>]. In this study, we further conducted a 5-year enterovirus surveillance comparing the VI-IFA and VP1-CODEHOP tests in northern Taiwan from 2008 to 2012.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Methods</title><sec id="sec003"><title>Ethics statement</title><p>This study was approved by the Ethics Committee of Chang Gung Memorial Hospital (CGMH) in accordance with the Helsinki Declaration. All experiments were performed in accordance with the approved guidelines of CGMH and the National Health Research Institutes. Written informed consent was obtained from guardians of all participating children in the study.</p></sec><sec id="sec004"><title>Study populations and clinical specimens</title><p>Clinical specimens were collected from a child cohort study which was initiated in northern Taiwan in 2006 [<xref rid="pone.0167532.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0167532.ref013" ref-type="bibr">13</xref>]. In the cohort study, throat swabs were obtained from these participating children for virus isolation if the participating children developed suspected enterovirus-like illnesses (HFMD and herpangina). Occasionally, pediatricians also collected throat swabs from the participating children who developed non-specific febrile illness for virus isolation during enterovirus seasons. Sera were obtained from participating children of the study cohort in the following schedule: neonates at birth (cord blood), and children at 6, 12, 24, 36, 48, 60, and 72 months of age. From 2008 to 2012, 431 cases provided throat swabs and 346 of them also provided paired sera samples collected before and after disease onset.</p></sec><sec id="sec005"><title>Virus isolation and IFA</title><p>Clinical specimens were inoculated onto four commercial cell lines (Hep2, MK2, MRC-5, and RD) obtained from ATCC (Manassas, Virginia, USA. Inoculated cells with cytopathic effects were harvested for IFA using a panel of antibodies which can detect multiple human viruses (respiratory syncytia virus, herpes simplex virus, influenza virus, parainfluenza virus, cytomegalovirus, and enterovirus). If the samples were positive for enterovirus testing, serotype-specific monoclonal antibodies were further employed to identify serotypes of enteroviruses. The type-specific monoclonal antibodies covered 23 serotypes as described in detail previously [<xref rid="pone.0167532.ref014" ref-type="bibr">14</xref>].</p></sec><sec id="sec006"><title>Viral RNA extraction and serotyping using CODEHOP</title><p>Viral RNA was extracted from the clinical specimens using a QIAamp Mini Viral RNA Extraction Kit (Qiagen, Germany). EV VP1 gene (350&#x02013;400 bp) was amplified as described in detail previously [<xref rid="pone.0167532.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0167532.ref015" ref-type="bibr">15</xref>]. The amplified DNA was sequenced using the ABI 3730 XL DNA Analyzer (Applied Biosystem Inc., Foster City, CA). Nucleotide sequences of the partial VP1 gene were analyzed using the BLAST search in the GenBank database to find the enterovirus serotype with the highest identity. Alignment of the nucleotide sequences and phylogenetic analysis were conducted as described in detail previously [<xref rid="pone.0167532.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0167532.ref015" ref-type="bibr">15</xref>]. Nucleotide sequences analyzed in this study have been submitted to GenBank (accession numbers KM816412-KM816579).</p></sec><sec id="sec007"><title>Serologic assay</title><p>Serum neutralizing antibody test has been widely used for diagnosis of enterovirus serotypes but it is not suitable for early diagnosis of enterovirus infections due to requirement of collecting paired sera and complexity of preparing virus stocks. Therefore, we only used serum neutralizing antibody test to verify serotypes of enterovirus infections when the VI-IFA and VP1-CODEHOP tests had discordant results. Enteroviruses used for serum neutralization tests include EV71, Coxsackievirus A2, A4, A5, A6, A9, A10, and A16. Laboratory methods for measuring serum neutralizing antibody titers followed standard protocols as described in detail previously [<xref rid="pone.0167532.ref016" ref-type="bibr">16</xref>].</p></sec><sec id="sec008"><title>Statistical analysis</title><p>The statistical significance in the detection rates of the two different tests was tested by the McNemar&#x02019;s test. Statistical analysis was performed using Epi-Info (CDC, Atlanta, GA) or SAS (SAS Institute, Cary, NC).</p></sec></sec><sec sec-type="results" id="sec009"><title>Results</title><sec id="sec010"><title>Detection and serotyping of enteroviruses</title><p>During 2008&#x02013;2012, throat swabs were collected from 431 children diagnosed with HFMD (105 cases), herpangina (255 cases), and other (including non-specific febrile and/or respiratory illness) (71 cases). Among the 431 cases, 208 (48%), and 250 (58%) were tested positive by the VI-IFA and VP1-CODEHOP tests, respectively (<xref rid="pone.0167532.t001" ref-type="table">Table 1</xref>).</p><table-wrap id="pone.0167532.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0167532.t001</object-id><label>Table 1</label><caption><title>Annual positive rates for enterovirus detection by two different laboratory methods, 2008&#x02013;2012.</title></caption><alternatives><graphic id="pone.0167532.t001g" xlink:href="pone.0167532.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="2" colspan="1">Year</th><th align="center" colspan="2" rowspan="1">Virus isolation</th><th align="center" colspan="2" rowspan="1">VP1-CODEHOP test</th></tr><tr><th align="center" rowspan="1" colspan="1">n/N</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">n/N</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">2008</td><td align="center" rowspan="1" colspan="1">18/61</td><td align="char" char="." rowspan="1" colspan="1">29.5%</td><td align="center" rowspan="1" colspan="1">22/61</td><td align="char" char="." rowspan="1" colspan="1">36.1%</td></tr><tr><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">21/49</td><td align="char" char="." rowspan="1" colspan="1">42.9%</td><td align="center" rowspan="1" colspan="1">26/49</td><td align="char" char="." rowspan="1" colspan="1">53.1%</td></tr><tr><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">89/160</td><td align="char" char="." rowspan="1" colspan="1">55.6%</td><td align="center" rowspan="1" colspan="1">112/160</td><td align="char" char="." rowspan="1" colspan="1">70.0%</td></tr><tr><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">40/86</td><td align="char" char="." rowspan="1" colspan="1">46.5%</td><td align="center" rowspan="1" colspan="1">47/86</td><td align="char" char="." rowspan="1" colspan="1">54.7%</td></tr><tr><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">40/75</td><td align="char" char="." rowspan="1" colspan="1">53.3%</td><td align="center" rowspan="1" colspan="1">43/75</td><td align="char" char="." rowspan="1" colspan="1">57.3%</td></tr><tr><td align="center" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">208/431</td><td align="char" char="." rowspan="1" colspan="1">48.3%</td><td align="center" rowspan="1" colspan="1">250/431</td><td align="char" char="." rowspan="1" colspan="1">58.0%</td></tr></tbody></table></alternatives></table-wrap><p>Overall, agreement and disagreement proportions between the two tests are 87.5% (377/431) and 12.5% (54/431), respectively (p&#x0003c;0.0001, McNemar&#x02019;s test) (<xref rid="pone.0167532.t002" ref-type="table">Table 2</xref>).</p><table-wrap id="pone.0167532.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0167532.t002</object-id><label>Table 2</label><caption><title>Detection of enteroviruses in 431 pediatric patients using two laboratory methods.</title></caption><alternatives><graphic id="pone.0167532.t002g" xlink:href="pone.0167532.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">Virus isolation</th><th align="center" colspan="2" rowspan="1">VP1 CODEHOP test</th></tr><tr><th align="center" rowspan="1" colspan="1">+</th><th align="center" rowspan="1" colspan="1">-</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">202</td><td align="center" rowspan="1" colspan="1">6</td></tr><tr><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">175</td></tr></tbody></table></alternatives></table-wrap><p>Among the six cases who were only detected using the VI-IFA, four provided paired sera and three of them were also confirmed with the serum neutralization test (<xref rid="pone.0167532.t003" ref-type="table">Table 3</xref>). Among the 48 cases who were only detected using the VP1-CODEHOP, 35 provided paired sera and all of them were also confirmed by the serum neutralization test (<xref ref-type="supplementary-material" rid="pone.0167532.s001">S1 Table</xref>). Among the 202 cases tested positive by both tests, 192 and 10 have consistent and inconsistent serotypes defined by the two tests, respectively. Eight of the 10 cases with inconsistent serotypes provided paired sera for verification. Based on the serum neutralization test for the eight cases, two and five cases showed consistent serotypes with the VI-IFA and VP1-CODEHOP tests, respectively (<xref rid="pone.0167532.t003" ref-type="table">Table 3</xref>). Overall, among the 47 cases who had inconsistent results between the VI-IFA and VP1-CODEHOP tests and provided paired sera for verification, correct diagnosis for the VI-IFA and VP1-CODEHOP tests were 5 (11%, 95% confidence interval 1&#x02013;19%) and 40 (85%, 95% confidence interval 75&#x02013;95%) cases, respectively. Therefore, the VP1-CODEHOP is more reliable for detection of human enteroviruses than the VI-IFA.</p><table-wrap id="pone.0167532.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0167532.t003</object-id><label>Table 3</label><caption><title>Verification using the serum neutralization test in patients who have inconsistent results by two different tests.</title></caption><alternatives><graphic id="pone.0167532.t003g" xlink:href="pone.0167532.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">ID</th><th align="center" rowspan="1" colspan="1">Virus isolation</th><th align="center" rowspan="1" colspan="1">VP1-CODEHOP</th><th align="center" rowspan="1" colspan="1">Neutralizing antibody seroconversion (serotype)</th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1">(A) Enterovirus infections were only detected by the virus isolation test</td></tr><tr><td align="center" rowspan="1" colspan="1">97035</td><td align="center" rowspan="1" colspan="1">CVA2</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">Yes (CVA2)</td></tr><tr><td align="center" rowspan="1" colspan="1">97065</td><td align="center" rowspan="1" colspan="1">CVA10</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">no post-infection serum</td></tr><tr><td align="center" rowspan="1" colspan="1">98050</td><td align="center" rowspan="1" colspan="1">CVA10</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">Yes (CVA10)</td></tr><tr><td align="center" rowspan="1" colspan="1">99037</td><td align="center" rowspan="1" colspan="1">CVA16</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">Yes (CVA16)</td></tr><tr><td align="center" rowspan="1" colspan="1">10021</td><td align="center" rowspan="1" colspan="1">CVA9</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">No (CVA9)</td></tr><tr><td align="center" rowspan="1" colspan="1">10067</td><td align="center" rowspan="1" colspan="1">CVA16</td><td align="center" rowspan="1" colspan="1">negative</td><td align="center" rowspan="1" colspan="1">no post-infection serum</td></tr><tr><td align="justify" colspan="4" rowspan="1">(B) Enterovirus detections were detected by the two tests but serotypes were inconsistent</td></tr><tr><td align="center" rowspan="1" colspan="1">99005</td><td align="center" rowspan="1" colspan="1">Untypable EV</td><td align="center" rowspan="1" colspan="1">CVA5</td><td align="center" rowspan="1" colspan="1">Yes (CVA5)</td></tr><tr><td align="center" rowspan="1" colspan="1">99031</td><td align="center" rowspan="1" colspan="1">CVA6</td><td align="center" rowspan="1" colspan="1">CVA16</td><td align="center" rowspan="1" colspan="1">No (CVA6); Yes (CVA16)</td></tr><tr><td align="center" rowspan="1" colspan="1">99068</td><td align="center" rowspan="1" colspan="1">CVA16</td><td align="center" rowspan="1" colspan="1">CVA6</td><td align="center" rowspan="1" colspan="1">No (CVA16); Yes (CVA6)</td></tr><tr><td align="center" rowspan="1" colspan="1">99094</td><td align="center" rowspan="1" colspan="1">CVA16</td><td align="center" rowspan="1" colspan="1">Positive but untypable</td><td align="center" rowspan="1" colspan="1">Yes (CVA16)</td></tr><tr><td align="center" rowspan="1" colspan="1">99095</td><td align="center" rowspan="1" colspan="1">CVA6</td><td align="center" rowspan="1" colspan="1">CVA16</td><td align="center" rowspan="1" colspan="1">No (CVA6); Yes (CVA16)</td></tr><tr><td align="center" rowspan="1" colspan="1">99104</td><td align="center" rowspan="1" colspan="1">Untypable EV</td><td align="center" rowspan="1" colspan="1">CVB2</td><td align="center" rowspan="1" colspan="1">no CVB2 virus</td></tr><tr><td align="center" rowspan="1" colspan="1">10039</td><td align="center" rowspan="1" colspan="1">Untypable EV</td><td align="center" rowspan="1" colspan="1">CVA6</td><td align="center" rowspan="1" colspan="1">Yes (CVA6)</td></tr><tr><td align="center" rowspan="1" colspan="1">10076</td><td align="center" rowspan="1" colspan="1">EV71</td><td align="center" rowspan="1" colspan="1">Positive but untypable</td><td align="center" rowspan="1" colspan="1">Yes (EV71)</td></tr><tr><td align="center" rowspan="1" colspan="1">10081</td><td align="center" rowspan="1" colspan="1">Untypable EV</td><td align="center" rowspan="1" colspan="1">CVA10</td><td align="center" rowspan="1" colspan="1">No (CVA10)</td></tr><tr><td align="center" rowspan="1" colspan="1">10162</td><td align="center" rowspan="1" colspan="1">CVB3</td><td align="center" rowspan="1" colspan="1">Positive but untypable</td><td align="center" rowspan="1" colspan="1">no post-infection serum</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>EV: enterovirus; CV: Coxsackievirus</p></fn></table-wrap-foot></table-wrap><p>Overall, the VI-IFA and VP1-CODEHOP tests respectively identified 13 and 15 serotypes in northern Taiwan, 2008&#x02013;2012. It is worth to note that two serotypes (CVB2 and Echo3) were only detected by the VP1-CODEHOP test. <xref rid="pone.0167532.t004" ref-type="table">Table 4</xref> shows the distribution of the top 5 enterovirus serotypes detected in northern Taiwan, 2008&#x02013;2012, which shows the overall serotype patterns were similar for the two tests. In addition, CVA2, CVA4, CVA6, CVA10, CVA16, and EV71 were the most prevalent serotypes and they were predominant in different years (<xref ref-type="supplementary-material" rid="pone.0167532.s002">S1 Fig</xref>).</p><table-wrap id="pone.0167532.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0167532.t004</object-id><label>Table 4</label><caption><title>Top five serotypes of human enteroviruses detected by two different tests during 2008&#x02013;2012 in northern Taiwan.</title></caption><alternatives><graphic id="pone.0167532.t004g" xlink:href="pone.0167532.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">Year and Test</th><th align="justify" rowspan="1" colspan="1">TOP 1</th><th align="justify" rowspan="1" colspan="1">TO P 2</th><th align="justify" rowspan="1" colspan="1">TOP 3</th><th align="justify" rowspan="1" colspan="1">TOP 4</th><th align="justify" rowspan="1" colspan="1">TOP 5</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">2008 Virus isolation</td><td align="left" rowspan="1" colspan="1">CVA2 (39%, 7)</td><td align="left" rowspan="1" colspan="1">EV71 (22%, 4)</td><td align="left" rowspan="1" colspan="1">CVA10 (17%, 3)</td><td align="left" rowspan="1" colspan="1">CVA5;CVA16;CVB4;CVB5 (6%, 1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">2008 CODEHOP</td><td align="left" rowspan="1" colspan="1">CVA2 (41%, 9)</td><td align="left" rowspan="1" colspan="1">EV71 (32%, 7)</td><td align="left" rowspan="1" colspan="1">CVA10</td><td align="left" rowspan="1" colspan="1">CVA5;CVA16;CVB4;CVB5 (5%, 1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">2009 Virus isolation</td><td align="left" rowspan="1" colspan="1">CVA6 (43%, 9)</td><td align="left" rowspan="1" colspan="1">CVA10 (29%, 6)</td><td align="left" rowspan="1" colspan="1">CVA4 (19%, 4)</td><td align="left" rowspan="1" colspan="1">CVA5;CVB1 (5%, 1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">2009 CODEHOP</td><td align="left" rowspan="1" colspan="1">CVA6 (38%, 10)</td><td align="left" rowspan="1" colspan="1">CVA10 (23%, 6)</td><td align="left" rowspan="1" colspan="1">CVA4 (15%, 4)</td><td align="left" rowspan="1" colspan="1">CVA5 (12%, 3)</td><td align="left" rowspan="1" colspan="1">EV71 (8%, 2)</td></tr><tr><td align="justify" rowspan="1" colspan="1">2010 Virus isolation</td><td align="left" rowspan="1" colspan="1">CVA16 (45%, 40)</td><td align="left" rowspan="1" colspan="1">CVA6 (25%, 22)</td><td align="left" rowspan="1" colspan="1">CVA4 (12%, 11)</td><td align="left" rowspan="1" colspan="1">CVA5 (9%, 8)</td><td align="left" rowspan="1" colspan="1">EV71 (3%, 3)</td></tr><tr><td align="justify" rowspan="1" colspan="1">2010 CODEHOP</td><td align="left" rowspan="1" colspan="1">CVA16 (41%, 46)</td><td align="left" rowspan="1" colspan="1">CVA6 (30%, 34)</td><td align="left" rowspan="1" colspan="1">CVA4;CVA5 (10%, 11)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">EV71 (4%, 4)</td></tr><tr><td align="justify" rowspan="1" colspan="1">2011 Virus isolation</td><td align="left" rowspan="1" colspan="1">CVA10 (43%, 17)</td><td align="left" rowspan="1" colspan="1">CVA9 (13%, 5)</td><td align="left" rowspan="1" colspan="1">CVA16 (10%, 4)</td><td align="left" rowspan="1" colspan="1">CVA4;CVA5 (8%, 3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">2011 CODEHOP</td><td align="left" rowspan="1" colspan="1">CVA10 (45%, 21)</td><td align="left" rowspan="1" colspan="1">CVA4 (13%, 6)</td><td align="left" rowspan="1" colspan="1">CVA5;CVA9 (11%, 5)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CVA6;CVA16 (6%, 3)</td></tr><tr><td align="justify" rowspan="1" colspan="1">2012 virus isolation</td><td align="left" rowspan="1" colspan="1">EV71 (65%, 26)</td><td align="left" rowspan="1" colspan="1">CVA2 (25%, 10)</td><td align="left" rowspan="1" colspan="1">CVB3 (8%, 3)</td><td align="left" rowspan="1" colspan="1">CVA10 (3%, 1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">2012 CODEHOP</td><td align="left" rowspan="1" colspan="1">EV71 (63%, 27)</td><td align="left" rowspan="1" colspan="1">CVA2 (26%, 11)</td><td align="left" rowspan="1" colspan="1">CVB3;CVA10 (5%, 2)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="justify" rowspan="1" colspan="1">2008&#x02013;2012 Virus isolation</td><td align="left" rowspan="1" colspan="1">CVA16 (22%, 45)</td><td align="left" rowspan="1" colspan="1">EV71 (16%, 34)</td><td align="left" rowspan="1" colspan="1">CVA6 (16%, 33)</td><td align="left" rowspan="1" colspan="1">CVA10 (13%, 27)</td><td align="left" rowspan="1" colspan="1">CVA2;CVA4 (9%, 18)</td></tr><tr><td align="justify" rowspan="1" colspan="1">2008&#x02013;2012 CODEHOP</td><td align="left" rowspan="1" colspan="1">CVA16 (20%, 50)</td><td align="left" rowspan="1" colspan="1">CVA6 (19%, 47)</td><td align="left" rowspan="1" colspan="1">EV71 (16%, 40)</td><td align="left" rowspan="1" colspan="1">CVA10 (12%, 31)</td><td align="left" rowspan="1" colspan="1">CVA2;CVA4 (9%, 21)</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec011"><title>Phylogenetic analysis of the prevalent serotypes</title><p>We further used CODEHOP-amplified partial VP1 nucleotide sequences of the six prevalent serotypes to conduct phylogenetic analyses for each prevalent serotype. There were 21 CVA2 cases detected by the VP1-CODEHOP test, including 9 in 2008, 1 in 2011, and 11 in 2012. Interestingly, three genetic clusters were identified based on phylogenetic analysis. The first cluster including 9 strains detected in 2008 is phylogenetically related to CVA2 strains circulating in Japan in 2003. The second cluster including 7 strains detected in 2012 may be phylogenetically related to CVA2 strains circulating in Russia in 2005. The third cluster including 5 strains detected in 2011&#x02013;2012 is phylogenetically related to the CVA2 strains causing severe neurological complications in Hong Kong in 2012 (<xref ref-type="fig" rid="pone.0167532.g001">Fig 1</xref>) [<xref rid="pone.0167532.ref017" ref-type="bibr">17</xref>]. However, all CVA2 cases detected in our study were mild infections without neurological complications.</p><fig id="pone.0167532.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0167532.g001</object-id><label>Fig 1</label><caption><title>Phylogenetic analysis of CVA2 strains detected in this study and reference strains based on partial VP1 sequences.</title><p>The reference strains were selected based on geographical and chronological distributions. The phylogenetic tree was constructed using the neighbor-joining method. Bootstrap values (&#x0003e;70%) are shown as percentage derived from 1,000 sampling at the nodes of the tree. Scale bar denotes number of nucleotide substitutions per site along the branches. Red, green, blue, purple and turquoise dots indicate the viruses detected in this study in 2008, 2009, 2010, 2011, and 2012, respectively.</p></caption><graphic xlink:href="pone.0167532.g001"/></fig><p>There were 20 CVA4 cases available for phylogenetic analysis (one was excluded for analysis due to short sequences), including 4 in 2009, 10 in 2010, and 6 in 2011. Interestingly, two genetic clusters and one outlier were identified based on phylogenetic analysis (<xref ref-type="fig" rid="pone.0167532.g002">Fig 2</xref>). The first cluster including 13 strains detected in 2009 and 2010 is phylogenetically related to CVA4 strains circulating in China in 2008&#x02013;2009. The second cluster including 6 strains detected in 2011 is phylogenetically related to CVA4 strains circulating in Greece in 2010 and India in 2007&#x02013;2009. All CVA4 cases detected in our study were mild infections without neurological complications.</p><fig id="pone.0167532.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0167532.g002</object-id><label>Fig 2</label><caption><title>Phylogenetic analysis of CVA4 strains detected in this study and reference strains based on partial VP1 sequences.</title><p>The reference strains were selected based on geographical and chronological distributions. The phylogenetic tree was constructed using the neighbor-joining method. Bootstrap values (&#x0003e;70%) are shown as percentage derived from 1,000 sampling at the nodes of the tree. Scale bar denotes number of nucleotide substitutions per site along the branches. Red, green, blue, purple and turquoise dots indicate the viruses detected in this study in 2008, 2009, 2010, 2011, and 2012, respectively.</p></caption><graphic xlink:href="pone.0167532.g002"/></fig><p>There were 47 CVA6 cases detected by the VP1-CODEHOP test, including 10 in 2009, 34 in 2010, and 3 in 2011. Interestingly, two genetic clusters were identified based on phylogenetic analysis (<xref ref-type="fig" rid="pone.0167532.g003">Fig 3</xref>). The first cluster including 10 strains detected in 2009 is phylogenetically related to multiple CVA6 strains circulating in different countries before 2009. The second cluster including 37 strains detected in 2010&#x02013;2011 is phylogenetically related to CVA6 strains circulating in Japan in 2009. All CVA6 cases detected in our study were mild infections without neurological complications but some studies have described onychomadesis desquamation and widespread blistering mucocutaneous reactions following CVA6 infection after 2009 [<xref rid="pone.0167532.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="pone.0167532.ref020" ref-type="bibr">20</xref>].</p><fig id="pone.0167532.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0167532.g003</object-id><label>Fig 3</label><caption><title>Phylogenetic analysis of CVA6 strains detected in this study and reference strains based on partial VP1 sequences.</title><p>The reference strains were selected based on geographical and chronological distributions. The phylogenetic tree was constructed using the neighbor-joining method. Bootstrap values (&#x0003e;70%) are shown as percentage derived from 1,000 sampling at the nodes of the tree. Scale bar denotes number of nucleotide substitutions per site along the branches. Red, green, blue, purple and turquoise dots indicate the viruses detected in this study in 2008, 2009, 2010, 2011, and 2012, respectively.</p></caption><graphic xlink:href="pone.0167532.g003"/></fig><p>There were 31 CVA10 cases detected by the VP1-CODEHOP test, including 2 in 2008, 6 in 2009, 21 in 2011, and 2 in 2012. Most of the CVA10 strains detected in 2011 could be grouped together and are phylogenetically related to CVA10 strains circulated in China in 2009. The other sporadic CVA10 strains detected in 2008, 2009 and 2012 did not have a clear phylogenetic pattern (<xref ref-type="fig" rid="pone.0167532.g004">Fig 4</xref>). All CVA10 cases detected in our study were mild infections without neurological complications.</p><fig id="pone.0167532.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0167532.g004</object-id><label>Fig 4</label><caption><title>Phylogenetic analysis of CVA10 strains detected in this study and reference strains based on partial VP1 sequences.</title><p>The reference strains were selected based on geographical and chronological distributions. The phylogenetic tree was constructed using the neighbor-joining method. Bootstrap values (&#x0003e;70%) are shown as percentage derived from 1,000 sampling at the nodes of the tree. Scale bar denotes number of nucleotide substitutions per site along the branches. Red, green, blue, purple and turquoise dots indicate the viruses detected in this study in 2008, 2009, 2010, 2011, and 2012, respectively.</p></caption><graphic xlink:href="pone.0167532.g004"/></fig><p>There were 49 CVA16 cases available for phylogenetic analysis (one was excluded for analysis due to short sequences), including 1 in 2008, 45 in 2010, and 3 in 2011. All CVA16 strains detected in northern Taiwan could be classified as genotype B1a and are phylogenetically related to the CVA16 strains circulating in China (<xref ref-type="fig" rid="pone.0167532.g005">Fig 5</xref>). All CVA16 cases detected in our study were mild infections without neurological complications.</p><fig id="pone.0167532.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0167532.g005</object-id><label>Fig 5</label><caption><title>Phylogenetic analysis of CVA16 strains detected in this study and reference strains based on partial VP1 sequences.</title><p>The reference strains were selected based on geographical and chronological distributions. The phylogenetic tree was constructed using the neighbor-joining method. Bootstrap values (&#x0003e;70%) are shown as percentage derived from 1,000 sampling at the nodes of the tree. Scale bar denotes number of nucleotide substitutions per site along the branches. Red, green, blue, purple and turquoise dots indicate the viruses detected in this study in 2008, 2009, 2010, 2011, and 2012, respectively.</p></caption><graphic xlink:href="pone.0167532.g005"/></fig><p>There were 40 EV71 cases detected by the VP1-CODEHOP test, including 7 in 2008, 2 in 2009, 4 in 2010, and 27 in 2012. None of the 40 EV71 cases developed neurological complications. Interestingly, two major genogroups (B and C) were identified based on phylogenetic analysis (<xref ref-type="fig" rid="pone.0167532.g006">Fig 6</xref>). Twenty eight strains were identified as genogroup B5, including 5 in 2008 and 23 in 2012. Most of the genotype B5 viruses detected in 2012 could be further classified as subgenotype B5c and they are phylogenetically different from the genogroup B5 viruses detected in 2008. Surprisingly, 6 sporadic strains detected in 2008, 2009, and 2012 were identified as genotype C2 which caused large-scale epidemics in Taiwan in 1998 but had disappeared in Taiwan from 1999 to 2007 [<xref rid="pone.0167532.ref021" ref-type="bibr">21</xref>]. Another 6 sporadic strains were identified as genotype C4 and they are phylogenetically related to C4 strains circulated in China after 2008 (<xref ref-type="fig" rid="pone.0167532.g006">Fig 6</xref>). The EV71 phylogenetic patterns identified in this study are consistent to other studies analyzing complete and partial VP1 sequences [<xref rid="pone.0167532.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0167532.ref022" ref-type="bibr">22</xref>].</p><fig id="pone.0167532.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0167532.g006</object-id><label>Fig 6</label><caption><title>Phylogenetic analysis of EV71 strains detected in this study and reference strains based on partial VP1 sequences.</title><p>The reference strains were selected based on geographical and chronological distributions. The phylogenetic tree was constructed using the neighbor-joining method. Bootstrap values (&#x0003e;70%) are shown as percentage derived from 1,000 sampling at the nodes of the tree. Scale bar denotes number of nucleotide substitutions per site along the branches. Red, green, blue, purple and turquoise dots indicate the viruses detected in this study in 2008, 2009, 2010, 2011, and 2012, respectively.</p></caption><graphic xlink:href="pone.0167532.g006"/></fig></sec></sec><sec sec-type="conclusions" id="sec012"><title>Discussion</title><p>Human enteroviruses have more than 100 serotypes which make laboratory diagnosis very challenging. The traditional methods based on VI-IFA are time-consuming and labor-intensive and could not detect novel serotypes before antisera are available. Alternatively, the VP1-CODEHOP test could be more sensitive and time-saving than the VI-IFA for detection and serotyping of human enteroviruses in clinical specimens. In this study, we compared these two diagnostic methods to conduct a 5-year enterovirus surveillance in 431 pediatric outpatients. As expected, detection rate of the VI-IFA was lower than that of the VP1-CODEHOP test (48% vs. 58%). After verification with the serotype-specific serum neutralization tests, we further confirmed high accuracy of the VP1-CODEHOP test, which is consistent with a previous study with a small sample size [<xref rid="pone.0167532.ref008" ref-type="bibr">8</xref>]. The previous study is a pilot study and included 110 cases for comparing two molecular methods (5'-UTR and VP1-CODEHOP) and the traditional method (virus isolation). The pilot study found that the VP1-CODEHOP is more suitable for detection and serotyping of enterovirus surveillance than the 5'-UTR. Therefore, the current study selected the VP1-CODEHOP for 5-year enterovirus surveillance (431 cases) and further conducted phylogenetic analysis of 6 prevalent enteroviruses to understand enterovirus evolution in Taiwan. Overall, the current study provides significant advances over the previous study.</p><p>In addition to having a higher detection rate, the VP1-CODEHOP test could be completed within 2&#x02013;3 days, which is much shorter than the VI-IFA (7&#x02013;14 days). Moreover, the VP1-CODEHOP test could further identify novel enterovirus genotypes based on phylogenetic analysis of partial VP1 gene sequences. As shown in this study, variant CVA2, CVA6, and EV71 viruses were identify using the VP1-CODEHOP test. Recently, variant CVA2 caused four complicated cases in Hong Kong in 2012 and two of them died [<xref rid="pone.0167532.ref017" ref-type="bibr">17</xref>]. Interestingly, we also detected 5 variant CVA2 strains in northern Taiwan but these 5 cases only developed mild symptoms. Similar results were also observed in the National Enterovirus Surveillance Database managed by Taiwan CDC (Dr H-S Wu unpublished data). Further studies are desirable to elucidate the epidemiological differences between Taiwan and Hong Kong. In addition, variant CVA6 caused unique clinical presentation in Finland in 2008 and we also detected this variant CVA6 causing similar symptoms in Taiwan in 2010 [<xref rid="pone.0167532.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="pone.0167532.ref020" ref-type="bibr">20</xref>]. EV71 seems to evolve quicker in the past 15 years and different EV71 genotypes have caused large-scale epidemics in tropical and subtropical Asia since 1997. Moreover, antigenic variations among different genotypes were observed based on serum neutralization test using rabbit and human antisera [<xref rid="pone.0167532.ref023" ref-type="bibr">23</xref>&#x02013;<xref rid="pone.0167532.ref027" ref-type="bibr">27</xref>]. Based on the VP1-CODEHOP test, we found that multiple EV71 genotypes co-circulated in 2008&#x02013;2012 but EV71 sub-genotypes B5b and B5c caused large-scale epidemics in 2008 and 2012, respectively, which are consistent with other studies analyzing full VP1 sequences and complete genomes [<xref rid="pone.0167532.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0167532.ref027" ref-type="bibr">27</xref>]. Although a degenerate primer set targeting conserved region of enteroviruses (5&#x02019;-UTR) had been widely used on molecular diagnostic systems, the 5&#x02019;-UTR-based molecular diagnosis cannot precisely identify serotypes of human enteroviruses [<xref rid="pone.0167532.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0167532.ref028" ref-type="bibr">28</xref>].</p><p>Overall, the VP1-CODEHOP test has multiple advantages over the VI-IFA test but it requires well-trained personnel. Moreover, the virus isolation could not be completely replaced because virus isolates are still required for conducting virological studies and sequencing full VP1 genes and virus genomes. Therefore, it would be desirable to use the VP1-CODEHOP test as the primary test for enterovirus surveillance. Then, clinical specimens from some CODEHOP-positive cases infected with representative or unique serotypes could be further selected for virus isolations. Recently, WHO has officially recommended the VP1-CODEHOP test for enterovirus surveillance [<xref rid="pone.0167532.ref029" ref-type="bibr">29</xref>].</p><p>Due to cyclic occurrence of EV71 epidemics, enterovirus surveillance in Taiwan and other Asian countries focus on clinical symptoms related to herpangina or neurological complications, which could not detect enteroviruses without causing these two symptoms and may not reflect comprehensive enterovirus circulation. In Taiwan, EV71 is currently the most devastating enterovirus. Due to being lack of EV71 vaccines and drugs, reducing contacts between patients and healthy children become the most important intervention to prevent EV71 infections and neurological complications. At the moment, class suspension for 5&#x02013;7 days in kindergartens and primary schools based on clinical diagnosis is the current strategy to prevent enterovirus-related severe infections in Taiwan. During 2010&#x02013;2013, about 4000&#x02013;6000 classes in Taiwan were temporarily suspended every year in order to preventing enteroviruses epidemics (<xref rid="pone.0167532.t005" ref-type="table">Table 5</xref>).</p><table-wrap id="pone.0167532.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0167532.t005</object-id><label>Table 5</label><caption><title>Correlation between class suspension and EV71 epidemics in Taiwan, 2010&#x02013;2013.</title></caption><alternatives><graphic id="pone.0167532.t005g" xlink:href="pone.0167532.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">Year</th><th align="center" rowspan="1" colspan="1">No. of EV Severe cases<xref ref-type="table-fn" rid="t005fn003">*</xref></th><th align="center" rowspan="1" colspan="1">No. (%) of EV71 Severe cases<xref ref-type="table-fn" rid="t005fn003">*</xref></th><th align="center" rowspan="1" colspan="1">No. of EV isolation by TW-CDC contract laboratory</th><th align="center" rowspan="1" colspan="1">No. (%) of EV71 isolation by TW-CDC contract laboratory</th><th align="center" rowspan="1" colspan="1">No. of classes suspended</th></tr></thead><tbody><tr><td align="justify" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">12 (75)</td><td align="center" rowspan="1" colspan="1">2636</td><td align="center" rowspan="1" colspan="1">51 (1.9)</td><td align="center" rowspan="1" colspan="1">5857</td></tr><tr><td align="justify" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">59 (100)</td><td align="center" rowspan="1" colspan="1">2172</td><td align="center" rowspan="1" colspan="1">349 (16.1)</td><td align="center" rowspan="1" colspan="1">3114</td></tr><tr><td align="justify" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">153</td><td align="center" rowspan="1" colspan="1">144 (94)</td><td align="center" rowspan="1" colspan="1">1744</td><td align="center" rowspan="1" colspan="1">923 (52.9)</td><td align="center" rowspan="1" colspan="1">6033</td></tr><tr><td align="justify" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">6 (50)</td><td align="center" rowspan="1" colspan="1">1454</td><td align="center" rowspan="1" colspan="1">22 (1.5)</td><td align="center" rowspan="1" colspan="1">5736</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p>Data source: Taiwan Centers for Disease Control (TW-CDC).</p></fn><fn id="t005fn002"><p>EV, enterovirus; EV71, enterovirus 71</p></fn><fn id="t005fn003"><p>* Different laboratory methods were used for different years so these data should be interpreted with caution.</p></fn></table-wrap-foot></table-wrap><p>Surprisingly, only sporadic enterovirus-related severe cases were detected in 2010 and 2013 but over 5000 classes were suspended in these two individual years. Class suspension for 5&#x02013;7 days could cause a lot of disturbances to a family as well as indirect burdens to a society. As shown in this study, the VP1-CODEHOP test could be employed to judge the necessity and duration of class suspensions. Currently, the VP1-CODEHOP test could be completed using the regular molecular equipment and its material costs are less than $20 USD per test. Comparing with the direct and indirect expenses due to unnecessary class suspensions every year, it could be cost-effective to establish the VP1-CODEHOP platform for decision-making of class suspensions in Taiwan [<xref rid="pone.0167532.ref030" ref-type="bibr">30</xref>].</p></sec><sec sec-type="supplementary-material" id="sec013"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0167532.s001"><label>S1 Table</label><caption><title>Verification using the serum neutralization test for patients who were negative in the enterovirus IFA test but positive in the VP1-CODEHOP test.</title><p>(DOCX)</p></caption><media xlink:href="pone.0167532.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0167532.s002"><label>S1 Fig</label><caption><title>Annual detection of prevalent enterovirus serotypes using molecular method (VP1-CODEHOP) in northern Taiwan, 2008~2012.</title><p>(TIF)</p></caption><media xlink:href="pone.0167532.s002.TIF"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors thank the referring physicians and parents of participating children. The authors also thank the Taiwan Centers for Disease Control for providing virus strains and enterovirus surveillance data.</p></ack><ref-list><title>References</title><ref id="pone.0167532.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>MS</given-names></name>, <name><surname>Tseng</surname><given-names>FC</given-names></name>, <name><surname>Wang</surname><given-names>JR</given-names></name>, <name><surname>Chi</surname><given-names>CY</given-names></name>, <name><surname>Chong</surname><given-names>P</given-names></name>, <name><surname>Su</surname><given-names>IJ</given-names></name>. <article-title>Challenges to licensure of enterovirus 71 vaccines</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2012</year>; <volume>6</volume>:<fpage>e1737</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0001737</pub-id>
<?supplied-pmid 22953003?><pub-id pub-id-type="pmid">22953003</pub-id></mixed-citation></ref><ref id="pone.0167532.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Solomon</surname><given-names>T</given-names></name>, <name><surname>Lewthwaite</surname><given-names>P</given-names></name>, <name><surname>Perera</surname><given-names>D</given-names></name>, <name><surname>Cardosa</surname><given-names>MJ</given-names></name>, <name><surname>McMinn</surname><given-names>P</given-names></name>, <name><surname>Ooi</surname><given-names>MH</given-names></name>. <article-title>Virology, epidemiology, pathogenesis, and control of enterovirus 71</article-title>. <source>Lancet Infect Dis</source>. <year>2010</year>; <volume>10</volume>:<fpage>778</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(10)70194-8</pub-id>
<?supplied-pmid 20961813?><pub-id pub-id-type="pmid">20961813</pub-id></mixed-citation></ref><ref id="pone.0167532.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>TS</given-names></name>, <name><surname>Shih</surname><given-names>FY</given-names></name>, <name><surname>Yen</surname><given-names>MY</given-names></name>, <name><surname>Wu</surname><given-names>JS</given-names></name>, <name><surname>Lu</surname><given-names>SW</given-names></name>, <name><surname>Chang</surname><given-names>KC</given-names></name>, <etal>et al</etal>
<article-title>Establishing a nationwide emergency department-based syndromic surveillance system for better public health responses in Taiwan</article-title>. <source>BMC Public Health</source>. <year>2008</year>; <volume>8</volume>:<fpage>18</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2458-8-18</pub-id>
<?supplied-pmid 18201388?><pub-id pub-id-type="pmid">18201388</pub-id></mixed-citation></ref><ref id="pone.0167532.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Chuang</surname><given-names>JH</given-names></name>, <name><surname>Huang</surname><given-names>AS</given-names></name>, <name><surname>Huang</surname><given-names>WT</given-names></name>, <name><surname>Liu</surname><given-names>MT</given-names></name>, <name><surname>Chou</surname><given-names>JH</given-names></name>, <name><surname>Chang</surname><given-names>FY</given-names></name>, <etal>et al</etal>
<article-title>Nationwide surveillance of influenza during the pandemic (2009&#x02013;10) and post-pandemic (2010&#x02013;11) periods in Taiwan</article-title>. <source>PLoS One</source>. <year>2012</year>; <volume>7</volume>:<fpage>e36120</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0036120</pub-id>
<?supplied-pmid 22545158?><pub-id pub-id-type="pmid">22545158</pub-id></mixed-citation></ref><ref id="pone.0167532.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Tsao</surname><given-names>LY</given-names></name>, <name><surname>Lin</surname><given-names>CY</given-names></name>, <name><surname>Yu</surname><given-names>YY</given-names></name>, <name><surname>Wang</surname><given-names>BT</given-names></name>. <article-title>Microchip, reverse transcription-polymerase chain reaction and culture methods to detect enterovirus infection in pediatric patients</article-title>. <source>Pediatr Int</source>. <year>2006</year>; <volume>48</volume>:<fpage>5</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1111/j.1442-200X.2006.02157.x</pub-id>
<?supplied-pmid 16490062?><pub-id pub-id-type="pmid">16490062</pub-id></mixed-citation></ref><ref id="pone.0167532.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Vuorinen</surname><given-names>T</given-names></name>, <name><surname>Vainionpaa</surname><given-names>R</given-names></name>, <name><surname>Hyypia</surname><given-names>T</given-names></name>. <article-title>Five years' experience of reverse-transcriptase polymerase chain reaction in daily diagnosis of enterovirus and rhinovirus infections</article-title>. <source>Clin Infect Dis</source>. <year>2003</year>; <volume>37</volume>:<fpage>452</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1086/376635</pub-id>
<?supplied-pmid 12884172?><pub-id pub-id-type="pmid">12884172</pub-id></mixed-citation></ref><ref id="pone.0167532.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Yeo</surname><given-names>A</given-names></name>, <name><surname>Phoon</surname><given-names>MC</given-names></name>, <name><surname>Tan</surname><given-names>EL</given-names></name>, <name><surname>Poh</surname><given-names>CL</given-names></name>, <name><surname>Quak</surname><given-names>SH</given-names></name>, <etal>et al</etal>
<article-title>The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains</article-title>. <source>Int J Infect Dis</source>. <year>2010</year>; <volume>14</volume>:<fpage>e1076</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2010.07.006</pub-id>
<?supplied-pmid 20952237?><pub-id pub-id-type="pmid">20952237</pub-id></mixed-citation></ref><ref id="pone.0167532.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Chiang</surname><given-names>PS</given-names></name>, <name><surname>Huang</surname><given-names>ML</given-names></name>, <name><surname>Luo</surname><given-names>ST</given-names></name>, <name><surname>Lin</surname><given-names>TY</given-names></name>, <name><surname>Tsao</surname><given-names>KC</given-names></name>, <name><surname>Lee</surname><given-names>MS</given-names></name>. <article-title>Comparing molecular methods for early detection and serotyping of enteroviruses in throat swabs of pediatric patients</article-title>. <source>PLoS One</source>. <year>2012</year>; <volume>7</volume>:<fpage>e48269</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0048269</pub-id>
<?supplied-pmid 23133580?><pub-id pub-id-type="pmid">23133580</pub-id></mixed-citation></ref><ref id="pone.0167532.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Rose</surname><given-names>TM</given-names></name>, <name><surname>Henikoff</surname><given-names>JG</given-names></name>, <name><surname>Henikoff</surname><given-names>S</given-names></name>. <article-title>CODEHOP (COnsensus-DEgenerate Hybrid Oligonucleotide Primer) PCR primer design</article-title>. <source>Nucleic Acids Res</source>. <year>2003</year>; <volume>31</volume>:<fpage>3763</fpage>&#x02013;<lpage>6</lpage>. <?supplied-pmid 12824413?><pub-id pub-id-type="pmid">12824413</pub-id></mixed-citation></ref><ref id="pone.0167532.ref010"><label>10</label><mixed-citation publication-type="book"><name><surname>Pallansch</surname><given-names>M</given-names></name>, <name><surname>Roos</surname><given-names>RP</given-names></name>. <chapter-title>Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses</chapter-title> In: <name><surname>Knipe</surname><given-names>DM</given-names></name>, <name><surname>Howley</surname><given-names>PM</given-names></name>, editors. <source>Fields Virology</source>. <edition>5th ed</edition>
<publisher-loc>New York</publisher-loc>: <publisher-name>Raven Press</publisher-name>; <year>2007</year> pp. <fpage>839</fpage>&#x02013;<lpage>93</lpage>.</mixed-citation></ref><ref id="pone.0167532.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Nix</surname><given-names>WA</given-names></name>, <name><surname>Oberste</surname><given-names>MS</given-names></name>, <name><surname>Pallansch</surname><given-names>MA</given-names></name>. <article-title>Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens</article-title>. <source>J Clin Microbiol</source>. <year>2006</year>; <volume>44</volume>:<fpage>2698</fpage>&#x02013;<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00542-06</pub-id>
<?supplied-pmid 16891480?><pub-id pub-id-type="pmid">16891480</pub-id></mixed-citation></ref><ref id="pone.0167532.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Luo</surname><given-names>ST</given-names></name>, <name><surname>Chiang</surname><given-names>PS</given-names></name>, <name><surname>Chao</surname><given-names>AS</given-names></name>, <name><surname>Liou</surname><given-names>GY</given-names></name>, <name><surname>Lin</surname><given-names>R</given-names></name>, <name><surname>Lin</surname><given-names>TY</given-names></name>, <etal>et al</etal>
<article-title>Enterovirus 71 maternal antibodies in infants, Taiwan</article-title>. <source>Emerg Infect Dis</source>. <year>2009</year>; <volume>15</volume>:<fpage>581</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.3201/eid1504.081550</pub-id>
<?supplied-pmid 19331737?><pub-id pub-id-type="pmid">19331737</pub-id></mixed-citation></ref><ref id="pone.0167532.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>MS</given-names></name>, <name><surname>Lin</surname><given-names>TY</given-names></name>, <name><surname>Chiang</surname><given-names>PS</given-names></name>, <name><surname>Li</surname><given-names>WC</given-names></name>, <name><surname>Luo</surname><given-names>ST</given-names></name>, <name><surname>Tsao</surname><given-names>KC</given-names></name>, <etal>et al</etal>
<article-title>An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features</article-title>. <source>Pediatr Infect Dis J</source>. <year>2010</year>; <volume>29</volume>:<fpage>1030</fpage>&#x02013;<lpage>4</lpage>. <?supplied-pmid 20543760?><pub-id pub-id-type="pmid">20543760</pub-id></mixed-citation></ref><ref id="pone.0167532.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Tsao</surname><given-names>KC</given-names></name>, <name><surname>Huang</surname><given-names>CG</given-names></name>, <name><surname>Huang</surname><given-names>YL</given-names></name>, <name><surname>Chen</surname><given-names>FC</given-names></name>, <name><surname>Huang</surname><given-names>PN</given-names></name>, <name><surname>Huang</surname><given-names>YC</given-names></name>, <etal>et al</etal>
<article-title>Epidemiologic features and virus isolation of enteroviruses in Northern Taiwan during 2000&#x02013;2008</article-title>. <source>J Virol Methods</source>. <year>2010</year>; <volume>165</volume>:<fpage>330</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/j.jviromet.2010.03.001</pub-id>
<?supplied-pmid 20214926?><pub-id pub-id-type="pmid">20214926</pub-id></mixed-citation></ref><ref id="pone.0167532.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Ortner</surname><given-names>B</given-names></name>, <name><surname>Huang</surname><given-names>CW</given-names></name>, <name><surname>Schmid</surname><given-names>D</given-names></name>, <name><surname>Mutz</surname><given-names>I</given-names></name>, <name><surname>Wewalka</surname><given-names>G</given-names></name>, <name><surname>Allerberger</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Epidemiology of enterovirus types causing neurological disease in Austria 1999&#x02013;2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes</article-title>. <source>J Med Virol</source>. <year>2009</year>; <volume>81</volume>:<fpage>317</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.21374</pub-id>
<?supplied-pmid 19107980?><pub-id pub-id-type="pmid">19107980</pub-id></mixed-citation></ref><ref id="pone.0167532.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>ML</given-names></name>, <name><surname>Chiang</surname><given-names>PS</given-names></name>, <name><surname>Luo</surname><given-names>ST</given-names></name>, <name><surname>Liou</surname><given-names>GY</given-names></name>, <name><surname>Lee</surname><given-names>MS</given-names></name>. <article-title>Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71</article-title>. <source>J Virol Methods</source>. <year>2010</year>; <volume>165</volume>:<fpage>42</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jviromet.2009.12.015</pub-id>
<?supplied-pmid 20036286?><pub-id pub-id-type="pmid">20036286</pub-id></mixed-citation></ref><ref id="pone.0167532.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Yip</surname><given-names>CC</given-names></name>, <name><surname>Lau</surname><given-names>SK</given-names></name>, <name><surname>Woo</surname><given-names>PC</given-names></name>, <name><surname>Wong</surname><given-names>SS</given-names></name>, <name><surname>Tsang</surname><given-names>TH</given-names></name>, <name><surname>Lo</surname><given-names>JY</given-names></name>, <etal>et al</etal>
<article-title>Recombinant coxsackievirus A2 and deaths of children, Hong Kong, 2012</article-title>. <source>Emerg Infect Dis</source>. <year>2013</year>; <volume>19</volume>:<fpage>1285</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3201/eid1908.121498</pub-id>
<?supplied-pmid 23876841?><pub-id pub-id-type="pmid">23876841</pub-id></mixed-citation></ref><ref id="pone.0167532.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Wei</surname><given-names>SH</given-names></name>, <name><surname>Huang</surname><given-names>YP</given-names></name>, <name><surname>Liu</surname><given-names>MC</given-names></name>, <name><surname>Tsou</surname><given-names>TP</given-names></name>, <name><surname>Lin</surname><given-names>HC</given-names></name>, <name><surname>Lin</surname><given-names>TL</given-names></name>, <etal>et al</etal>
<article-title>An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010</article-title>. <source>BMC Infect Dis</source>. <year>2011</year>; <volume>11</volume>:<fpage>346</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2334-11-346</pub-id>
<?supplied-pmid 22168544?><pub-id pub-id-type="pmid">22168544</pub-id></mixed-citation></ref><ref id="pone.0167532.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Chung</surname><given-names>WH</given-names></name>, <name><surname>Shih</surname><given-names>SR</given-names></name>, <name><surname>Chang</surname><given-names>CF</given-names></name>, <name><surname>Lin</surname><given-names>TY</given-names></name>, <name><surname>Huang</surname><given-names>YC</given-names></name>, <name><surname>Chang</surname><given-names>SC</given-names></name>, <etal>et al</etal>
<article-title>Clinicopathologic analysis of coxsackievirus a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions</article-title>. <source>J Infect Dis</source>. <year>2013</year>; <volume>208</volume>:<fpage>1968</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jit383</pub-id>
<?supplied-pmid 23904296?><pub-id pub-id-type="pmid">23904296</pub-id></mixed-citation></ref><ref id="pone.0167532.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Osterback</surname><given-names>R</given-names></name>, <name><surname>Vuorinen</surname><given-names>T</given-names></name>, <name><surname>Linna</surname><given-names>M</given-names></name>, <name><surname>Susi</surname><given-names>P</given-names></name>, <name><surname>Hyypia</surname><given-names>T</given-names></name>, <name><surname>Waris</surname><given-names>M</given-names></name>. <article-title>Coxsackievirus A6 and hand, foot, and mouth disease, Finland</article-title>. <source>Emerg Infect Dis</source>. <year>2009</year>; <volume>15</volume>:<fpage>1485</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3201/eid1509.090438</pub-id>
<?supplied-pmid 19788821?><pub-id pub-id-type="pmid">19788821</pub-id></mixed-citation></ref><ref id="pone.0167532.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Chia</surname><given-names>MY</given-names></name>, <name><surname>Chiang</surname><given-names>PS</given-names></name>, <name><surname>Chung</surname><given-names>WY</given-names></name>, <name><surname>Luo</surname><given-names>ST</given-names></name>, <name><surname>Lee</surname><given-names>MS</given-names></name>. <article-title>Epidemiology of enterovirus 71 infections in Taiwan</article-title>. <source>Pediatr Neonatol</source>. <year>2014</year>; <volume>55</volume>:<fpage>243</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.pedneo.2013.07.007</pub-id>
<?supplied-pmid 24120535?><pub-id pub-id-type="pmid">24120535</pub-id></mixed-citation></ref><ref id="pone.0167532.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>YP</given-names></name>, <name><surname>Lin</surname><given-names>TL</given-names></name>, <name><surname>Lin</surname><given-names>TH</given-names></name>, <name><surname>Wu</surname><given-names>HS</given-names></name>. <article-title>Antigenic and genetic diversity of human enterovirus 71 from 2009 to 2012, Taiwan</article-title>. <source>PLoS One</source>. <year>2013</year>; <volume>8</volume>:<fpage>e80942</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0080942</pub-id>
<?supplied-pmid 24348916?><pub-id pub-id-type="pmid">24348916</pub-id></mixed-citation></ref><ref id="pone.0167532.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Chia</surname><given-names>MY</given-names></name>, <name><surname>Chung</surname><given-names>WY</given-names></name>, <name><surname>Chiang</surname><given-names>PS</given-names></name>, <name><surname>Chien</surname><given-names>YS</given-names></name>, <name><surname>Ho</surname><given-names>MS</given-names></name>, <name><surname>Lee</surname><given-names>MS</given-names></name>. <article-title>Monitoring antigenic variations of enterovirus 71: implications for virus surveillance and vaccine development</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2014</year>; <volume>8</volume>:<fpage>e3044</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0003044</pub-id>
<?supplied-pmid 25058733?><pub-id pub-id-type="pmid">25058733</pub-id></mixed-citation></ref><ref id="pone.0167532.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>ML</given-names></name>, <name><surname>Chiang</surname><given-names>PS</given-names></name>, <name><surname>Chia</surname><given-names>MY</given-names></name>, <name><surname>Luo</surname><given-names>ST</given-names></name>, <name><surname>Chang</surname><given-names>LY</given-names></name>, <name><surname>Lin</surname><given-names>TY</given-names></name>, <etal>et al</etal>
<article-title>Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2013</year>; <volume>7</volume>:<fpage>e2067</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0002067</pub-id>
<?supplied-pmid 23459633?><pub-id pub-id-type="pmid">23459633</pub-id></mixed-citation></ref><ref id="pone.0167532.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>H</given-names></name>, <name><surname>Chen</surname><given-names>W</given-names></name>, <name><surname>Chang</surname><given-names>H</given-names></name>, <name><surname>Tang</surname><given-names>R</given-names></name>, <name><surname>Zhao</surname><given-names>J</given-names></name>, <name><surname>Gan</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Genetic analysis of the VP1 region of enterovirus 71 reveals the emergence of genotype A in central China in 2008</article-title>. <source>Virus Genes</source>. <year>2010</year>; <volume>41</volume>:<fpage>1</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1007/s11262-010-0472-9</pub-id>
<?supplied-pmid 20306124?><pub-id pub-id-type="pmid">20306124</pub-id></mixed-citation></ref><ref id="pone.0167532.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>J</given-names></name>, <name><surname>Luo</surname><given-names>Z</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Xu</surname><given-names>Z</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Fan</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Phylogenetic analysis of Enterovirus 71 circulating in Beijing, China from 2007 to 2009</article-title>. <source>PLoS One</source>. <year>2013</year>; <volume>8</volume>:<fpage>e56318</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0056318</pub-id>
<?supplied-pmid 23418551?><pub-id pub-id-type="pmid">23418551</pub-id></mixed-citation></ref><ref id="pone.0167532.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Luo</surname><given-names>ST</given-names></name>, <name><surname>Chiang</surname><given-names>PS</given-names></name>, <name><surname>Chung</surname><given-names>WY</given-names></name>, <name><surname>Chia</surname><given-names>MY</given-names></name>, <name><surname>Tsao</surname><given-names>KC</given-names></name>, <name><surname>Wang</surname><given-names>YH</given-names></name>, <etal>et al</etal>
<article-title>Reemergence of enterovirus 71 epidemic in northern Taiwan, 2012</article-title>. <source>PLoS One</source>. <year>2015</year>; <volume>10</volume>:<fpage>e0116322</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0116322</pub-id>
<?supplied-pmid 25774888?><pub-id pub-id-type="pmid">25774888</pub-id></mixed-citation></ref><ref id="pone.0167532.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Yoke-Fun</surname><given-names>C</given-names></name>, <name><surname>AbuBakar</surname><given-names>S</given-names></name>. <article-title>Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes</article-title>. <source>BMC Microbiol</source>. <year>2006</year>; <volume>6</volume>:<fpage>74</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2180-6-74</pub-id>
<?supplied-pmid 16939656?><pub-id pub-id-type="pmid">16939656</pub-id></mixed-citation></ref><ref id="pone.0167532.ref029"><label>29</label><mixed-citation publication-type="journal"><collab>World Health Organization</collab>. <source>Enterovirus surveillance guidelines. Guidelines for enterovirus surveillance in support of the Polio Eradication Initiative</source>. <year>2015</year>:<volume>40</volume>.</mixed-citation></ref><ref id="pone.0167532.ref030"><label>30</label><mixed-citation publication-type="book"><collab>World Health Organization</collab>. <source>A Guide to Clinical Management and Public Health Response for Hand, Foot and Mouth Disease (HFMD)</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>; <year>2011</year>.</mixed-citation></ref></ref-list></back></article>